KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Assets Average (2016 - 2025)

Historic Assets Average for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $40.3 billion.

  • Teva Pharmaceutical Industries' Assets Average fell 59.2% to $40.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $40.3 billion, marking a year-over-year decrease of 59.2%. This contributed to the annual value of $40.0 billion for FY2025, which is 329.81% down from last year.
  • Teva Pharmaceutical Industries' Assets Average amounted to $40.3 billion in Q4 2025, which was down 59.2% from $40.0 billion recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Assets Average ranged from a high of $49.8 billion in Q1 2021 and a low of $38.9 billion during Q1 2025
  • Moreover, its 5-year median value for Assets Average was $43.2 billion (2023), whereas its average is $43.8 billion.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Assets Average plummeted by 1166.31% in 2021 and then tumbled by 59.2% in 2025.
  • Teva Pharmaceutical Industries' Assets Average (Quarter) stood at $47.8 billion in 2021, then fell by 7.59% to $44.1 billion in 2022, then fell by 3.05% to $42.8 billion in 2023, then fell by 5.25% to $40.5 billion in 2024, then fell by 0.59% to $40.3 billion in 2025.
  • Its Assets Average was $40.3 billion in Q4 2025, compared to $40.0 billion in Q3 2025 and $39.3 billion in Q2 2025.